With the massive digitalization of many processes involved in human activities, electronic medical records (EMR) are being increasingly deployed in medical centers. EMR have the potential to become a main major real-life data source for future medical research and evaluation of practice. Multiple sclerosis is a paradigmatic example of a complex disease that can benefit from this new source of information. Today, researchers and clinicians alike have access to tools allowing an en masse identification of multiple sclerosis patients, and extraction of demographics and clinical variables with high accuracy. However no matter how "big" the (EMR) data might be, biases are inherent to EMR data generation. These have to be studied and eventually accounted for in analysis in order to fulfill the promise of personalized medicine for all, and carrying out large clinical and research studies in multiple sclerosis.
Introduction
Electronic medical records (EMR) consist of a digital version of clinicians' paper charts. All patients' information, such as clinical notes, medications and laboratory tests results, are saved and stored in an electronic format. These records are initially conceived to help healthcare providers to track, secure and transmit health data over time, to facilitate sharing of information within one organization. A major driver of EMR adoption and deployment is also to address billing of the procedures or clinical visits. However, all these data are usually not fully interoperable between organizations. EMR are part of electronic health records systems, and those are meant to be accessible and useable by all providers from different organizations involved in a patient's care, and by the patient himself.
1 EMR systems hold various data types, including structured (codified) data that are easily extractable, as well as unstructured (free-text) data that require more sophisticated extraction procedures. 2 One challenge in using EMR data for research is that EMR are primarily designed to address clinical care and billing, and not necessarily to support research. 2, 3 Furthermore, in order to avoid privacy breaches, researchers have to deal with security constraints when accessing and using EMR data. 2 However, in recent years, there has been an increasing use of EMR data in research.
Use of electronic medical records in multiple sclerosis research
Although research was never a primary goal of EMR system architecture, clinicians and researchers increasingly have the opportunity to leverage clinical data for research-based analyses. 4 A Pubmed search for ["Electronic Medical Records" OR "Electronic Health Records"] and "Multiple Sclerosis" in "English" language retrieved 108 results as of November 2017. The first article was published less than 15 years ago, in 2003, with a growing number of publications since 2010, showing the recent interest in EMR (Fig. 1) . Most of the studies published so far fall into two main categories: epidemiological and clinical studies.
Epidemiological studies
A variety of population studies have been published so far, focusing on several characteristics of the disease. Since the introduction of certain vaccinations, debates have emerged about their possible trigger role in developing multiple sclerosis (MS). 5 Some studies leveraged data from EMR to study the association of vaccination with MS and failed to identify any long-term association, including for hepatitis B and human papillomavirus vaccination. 6, 7 EMR data also allow the possibility for carrying out comorbidity and mortality analyses. Studies using patients identified through EMR showed that MS patients are more likely to have been diagnosed with inflammatory bowel disease, uveitis and Bell's palsy before being diagnosed with MS, and appear more likely to develop inflammatory bowel disease, uveitis, Bell's palsy, GuillainBarr e syndrome and bullous pemphigoid during their disease course. However, they are more or less likely to have been diagnosed with rheumatoid arthritis, lupus, psoriasis or type 1 diabetes. 8 Other studies showed an association of ischemic heart disease, fibromyalgia, metabolic syndromes and epilepsy in the MS population compared with the general population. [9] [10] [11] [12] Mortality EMR-based studies showed that the initial presentation by MS type (progressive MS), higher level of disability, and associated motor, sensory and cerebellar concerns are significant predictors of MS-related mortality in a cohort of USA veterans, 13 and suggested that MS survival is also influenced by patient comorbidities and lifestyles factors in addition to autoimmune processes.
14 Demographics data stored in EMR enabled researchers to also study differences in the incidence or prevalence of MS over time, or among different populations based on ethnicity, sex or geographic location. For example, it has been observed that there is a higher incidence of MS in children of African ancestry compared with children of European ancestry, 15 a lower prevalence of MS among populations of African and Asian ancestries compared with a population of European ancestry in London, 16 a similar prevalence of the disease in a district of Spain compared with the prevalence reported in other regions in Spain 17 and a slight increase of MS in recent years in the Netherlands, especially among women. 18 Environmental studies are also possible with EMR data, with one study suggesting that air pollution might have a role in determining MS occurrence and relapses. 19 Finally, some studies leveraged EMR data to study the relationship of pregnancy and MS, and showed that characteristics of pregnancies of mothers with MS are generally normal, 20 and that there is no support for a role of maternal and perinatal factors in influencing MS risk. 21 
Clinical studies
Clinical studies, most of them treatment-related, are also beneficiating from EMR data. Studies focusing on fingolimod, an MS-specific treatment, showed that it is well tolerated during first-dose observation and adverse events were self limited, 22 and rebound events can occur after ceasing treatment, even with short washout periods, and might perpetuate despite steroid treatment or the immediate use of fast-acting immune therapies. 23 A recent study showed that later initiation of disease-modifying drug treatments is associated with a greater likelihood of relapse compared with earlier initiation. 24 A study from Cleveland Clinic using EMR data of MS patients identified three subgroups of patients with different depression level trajectories, 25 and another study applied a natural language processing (NLP)-based classification on clinical notes to identify MS patients before the initial recognition by their healthcare providers. 26 
EMR research in the era of big data
Most of the studies published so far only focused on the diagnostic billing ICD-9 code (340 for MS) in order to identify and select MS patients in the EMR. Then, investigators usually manually review the electronic records to discard false positives and extract their variables of interest for the selected patients. However, this work is laborious and timeconsuming. Recently, several algorithms have been created to automatically identify MS patients en masse in the EMR, and extract their demographics and clinical data.
Automatic identification of MS patients in EMR
Few, but robust, algorithms have been published so far for identifying MS patients in EMR systems. Instead of focusing only on ICD-9 codes, these algorithms are based on ICD-9 codes, MS specific medications and use NLP in order to find specific text matches in clinical notes. A study has indeed proved that a combination of multiple EMR components provides a more consistent and higher performance than a single one. 27 The number of identified patients is high, usually several thousand. Ritchie et al. 28 and Davis et al. 29 implemented the first complex algorithms to accurately and automatically identify MS patients from the Vanderbilt EMR system, with a high positive predictive value (PPV) of 96%. Xia et al. developed a classification algorithm based on ICD-9 codes, codified and NLPextracted variables to identify MS patients with a sensitivity of 82.7% and a PPV of 92.1%. 30 Krysko et al. also developed an algorithm to identify MS patients from Ontario, Canada, electronic health records, and were able to identify patients with high sensitivity (91.5%) and high PPV (98.7%). 31 Nelson et al. identified more than 7000 patients from the Veterans Affairs EMR system. 32 Recently, Damotte et al. modified algorithms from Davis et al. to accurately identify MS patients from the University of California at San Francisco EMR system, and made the algorithms freely available to the community on the GitHub platform. 33 Their algorithms were developed using the widely used R software, and also reached a high PPV of 95% and a high sensitivity of 94%. Theses estimates reflect both the nature of the algorithms and the nature of the coded habits of the institutions, which limits transferability of the results.
Automatic data extraction from EMR
In most EMR studies, investigators manually reviewed EMR to extract variables of interest.
Recently, a few groups have focused on creating algorithms to automatically and accurately extract demographics and clinical data from EMR of MS patients. 29, 32, 33 In addition to the easily extractable medications and laboratory test results, they used NLP on the text of clinical notes to extract MSrelated clinical variables, such as the Expanded Disability Status Scale score, timed 25-foot walk, MS subtype and year of onset. These NLP extractions are of good quality with high sensitivities and PPV, excepted for year of onset, for which the extraction is less reliable. Damotte et al. also made their extraction algorithms freely available to the community on the GitHub platform. 33 Xia et al. also tested whether MS variables, such as brain volume and disease severity, can be derived from EMR data. 30 Whereas incorporating existing EMR variables is not informative for deriving brain volume measures, incorporation of NLP-extracted variables is highly informative for deriving the Multiple Sclerosis Severity Score, a commonly used score in MS research. 34 An MS ontology providing a semantic framework capable of automatically extract information from MS patients EMR has also been published. 35 When developing algorithms to extract variables from unstructured data, it is important to carry out a validation step by manually reviewing a subset of notes. It is a laborious, but mandatory, process that will inform the researcher about the accuracy of the data that they are going to use. Furthermore, although the overall process of extraction of unstructured data is similar between organizations, algorithms need to be adjusted to consider the specificity of the data recorded in other centers. This requires people with experience in coding and data science.
The future of EMR-based research studies
It is now accepted that EMR can be of great value for research studies, as it represents an important source of longitudinal, in-depth and real-world data for a high number of patients. They also have the advantage of being accessible without requiring excessive time and financial resources of the researchers. 4, 36 There are several immediate potential applications for EMR-derived data, including evaluation of practice, health economics, large-scale observational analyses and clinical studies, and efficient identification of candidates eligible for invitation to participate in traditional clinical research studies. 33 It can also be used for basic research. Proof-of-concept studies carried out genetic association analyses on MS patients identified from EMR. 28, 37 A Phenome-Wide Association Study with 4841 ICD-9 based phenotypes replicated the association of HLA-DRB1*15:01 with MS. 38 Recently, a targeted genetic association analysis was carried out on patients with MS, Crohn's disease or rheumatoid arthritis phenotype, and authors found a pathway indicative of a bacterial pathogenesis risk for autoimmunity in a joint autoimmune disease model. 39 Research on side phenotypes, such as severity of the disease or treatment responses, could also benefit from EMR data, as these studies are today suffering from small sample sizes resulting from the stratification of cohorts based on those secondary phenotypes. From this perspective of using these EMR MS populations and data for research, it has also been proved that an EMR population has several expected MS epidemiological features from MS natural history, and that EMR-extracted dataExpanded Disability Status Scale, timed 25-foot walk and MS subtype -strongly correlate with data recorded in a research database. 33 
EMR data and personalized medicine
Today, one of the main goals in health is to achieve personalized medicine. This will require building very strong and powerful reference cohorts. The EMR MS population has the potential to allow us to build those strong reference MS cohorts. This would enable large-scale comparisons of the long-term disease trajectory of any individual patient with the trajectories of others in the reference cohort, identify a subcohort with similar characteristics to the patient in question, and ultimately predict future outcomes and guide personalized, data-driven, management options. 40 EMR data can also be used in clinics. The values extracted from EMR can be displayed and referenced quickly to track changes in the progression of patients, improving the quality of discussion between the clinician and patient. 36 The MS BioScreen, a new and innovative digital tool, enables the integration and display of a unique navigation interface containing different types of patient information, and can be easily used in clinical practice (Fig. 2) . 41 MS BioScreen typically leverages the access to individual data of a patient of interest to represent that information in the context of reference distribution of complex data.
Challenges
EMR data have great promise; however, it is important to understand the challenges and limits researchers and clinicians will face with these data. Because research was not the primary goal of EMR, clinical data might not be collected or recorded consistently throughout the records, while it is the case in research cohorts. 36 Whereas prospective research cohorts tend to systematically record disease-specific variables using high-quality standards, some of these variables tend to be much sparser in EMR-derived data. Data recorded in research databases also go Figure 2 From electronic medical records (EMR) data to personalized medicine. Steps for using EMR data in personalized medicine. EMR data are extracted from the EMR system and processed into structured fields. Then, data are uploaded in a new database for use in personalized medicine, such as the MS Bioscreen platform for multiple sclerosis. 41 through systematic quality control, leading to very accurate information, whereas this quality control cannot be carried out for EMR data, or only for a small subset of patients. 4 Future strategies to improve how EMR can support the clinical mission and record MS-specific variables with greater fidelity have the potential to make big data even more useful. As structured variables can be easily extracted with high accuracy without the use of NLP, future EMR notes should offer structured fields for key MSspecific variables in addition to just free-text. 36 Another challenge will be to consider and understand the biases that can be introduced in analyses because of EMR data. By definition, EMR data contains missing data, but imputation strategies of those missing data could be a solution. 42 Potential information biases of EMR-based data have also been identified, including that moderately severe patients tend to have more clinical encounters in the EMR system and correspondingly more MS-related metric values extracted per year. 33 This could confound analyses. Recruitment bias can also occur when using EMR patients for research, depending on the characteristics of the population followed at one specific organization.
Conclusions
The recent adoption of EMR systems by several medical centers allows researchers to enter into a new era of data-driven research. Researchers, clinicians and data scientists are now provided with the bioinformatics tools required for identifying MS patients, and extracting demographics and clinical data en masse. We are now shifting from low sample size cohorts, but with high-quality data, to an excess of data but with sparser information. However, the important amount of data gives the opportunity to carry out longitudinal and powerful studies on the disease, at an unprecedented level. A variety of studies are possible: epidemiological, clinical and basic research studies. The hot topic of personalized medicine will also benefit from EMR data, but it is also important to understand and consider their limits, as well as the security constraints and regulatory context of the use of EMR data that contain private information.
